We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Synthetic Biologics Initiates Manufacturing of SYN-004 for Use in Preclinical and Clinical Trials

News   Oct 17, 2013

 
Synthetic Biologics Initiates Manufacturing of SYN-004 for Use in Preclinical and Clinical Trials
 
 
 

RELATED ARTICLES

Obesity & Vitamin D Deficiency May Indicate Greater Breast Cancer Risk

News

New study demonstrates that postmenopausal women have an increased risk of vitamin D deficiency at the time of breast cancer diagnosis, associated with a higher rate of obesity.

READ MORE

Experimental Nasal Influenza Vaccine Tested in Kids, Teens

News

NIH-supported Phase 1 trial of potential broadly protective vaccine.

READ MORE

Gout Get Outta Here

News

Researchers found a significant reduction in risk of gout attacks among patients who received the drug (canakinumab) that targets a key inflammatory molecule, suggesting a new target for therapeutic strategies to prevent gout attacks.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE